ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Cardiac resynchronization treatment in a patient with hypertrophic cardiomyopathy after heart transplantation [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2013; 41(1): 72-74 | DOI: 10.5543/tkda.2013.32855

Cardiac resynchronization treatment in a patient with hypertrophic cardiomyopathy after heart transplantation

Ahmet Vural1, Gökhan Ertaş2, Ayşen Ağaçdiken1
1Department of Cardiology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey
2Department of Cardiology, Bezmi Alem Vakif University Faculty of Medicine, Istanbul, Turkey

Hypertrophic cardiomyopathy (HCM) is characterized by heterogeneous clinical expression. Cardiac transplantation continues to be the gold standard for the treatment of end-stage cardiac diseases refractory to medical therapy. We presented a 27-year-old female patient with HCM who underwent successful cardiac resynchronization therapy after cardiac transplantation. Our patient had an indication for standard pacing. However, previous reports have shown that right ventricular apical pacing might lead to adverse clinical outcomes in patients with heart failure. We have discussed cardiac resynchronization therapy after heart transplantation in patients with standard pacing indications.

Keywords: Atrial fibrillation/therapy, cardiac pacing, artificial; heart failure/therapy; ventricular dysfunction, left; tachycardia, ventricular/ etiology.

How to cite this article
Ahmet Vural, Gökhan Ertaş, Ayşen Ağaçdiken. Cardiac resynchronization treatment in a patient with hypertrophic cardiomyopathy after heart transplantation. Turk Kardiyol Dern Ars. 2013; 41(1): 72-74

Corresponding Author: Gökhan Ertaş, Türkiye
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.